Optimal Use of Lenvatinib in the Treatment of Advanced Thyroid Cancer
Cancers of the Head & Neck
doi 10.1186/s41199-017-0026-0
Full Text
Open PDFAbstract
Available in full text
Date
October 24, 2017
Authors
Publisher
Springer Science and Business Media LLC